Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BCAAem is a specific formulation of branched-chain amino acids (BCAAs), which are essential amino acids comprising leucine, isoleucine, and valine. These amino acids are vital for various physiological processes, including protein synthesis, energy production, and mitochondrial function. BCAAem has been investigated in clinical studies for its potential therapeutic effects, particularly in addressing conditions such as malnutrition, frailty, and sarcopenia in elderly patients, and its role in healthy aging. It is believed to exert its effects by activating key cellular pathways involved in muscle metabolism and cellular energy regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BCAAem.